Cargando…
Rankl expression predicts poor prognosis in gastric cancer patients: results from a retrospective and single-center analysis
The receptor activator of nuclear factor κB ligand (RANKL)/RANK pathway plays an important role in the prognosis of several solid tumor types, but its role in gastric cancer prognosis has been poorly characterized. A total of 116 gastric cancer patients who underwent surgical resection were enrolled...
Autores principales: | Zhang, X., Song, Y., Song, N., Zhang, L., Wang, Y., Li, D., Wang, Z., Qu, X., Liu, Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769752/ https://www.ncbi.nlm.nih.gov/pubmed/29340518 http://dx.doi.org/10.1590/1414-431X20176265 |
Ejemplares similares
-
Caveolin-1 enhances RANKL-induced gastric cancer cell migration
por: Wang, Yan, et al.
Publicado: (2018) -
High Hepsin expression predicts poor prognosis in Gastric Cancer
por: Zhang, Mingming, et al.
Publicado: (2016) -
Notch1 activation is a poor prognostic factor in patients with gastric cancer
por: Zhang, H, et al.
Publicado: (2014) -
RANKL/RANK promotes the migration of gastric cancer cells by interacting with EGFR
por: Wan, Xing, et al.
Publicado: (2020) -
RANKL/RANK pathway abrogates cetuximab sensitivity in gastric cancer cells via activation of EGFR and c-Src
por: Zhang, Xiaomeng, et al.
Publicado: (2017)